VACCITECH (SP.ADR)/1 (2AB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.051x

Based on the latest financial reports, VACCITECH (SP.ADR)/1 (2AB) has a cash flow conversion efficiency ratio of -0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.37 Million ≈ $-3.94 Million USD) by net assets (€66.48 Million ≈ $77.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

VACCITECH (SP.ADR)/1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how VACCITECH (SP.ADR)/1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of VACCITECH (SP.ADR)/1 for a breakdown of total debt and financial obligations.

VACCITECH (SP.ADR)/1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VACCITECH (SP.ADR)/1 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pure Hydrogen Corporation Ltd AU:PH2	-0.252x
PC Direct Inc KQ:051380	0.402x
Yorbeau Resources Inc TO:YRB	0.019x
Sikko Industries Limited NSE:SIKKO	-0.100x
Bangsaphan Barmill Public Company Limited BK:BSBM	-0.090x
Form Bio Co. Ltd. KQ:377220	-0.070x
Telefast Indonesia JK:TFAS	0.023x
exax Inc KQ:060230	-0.030x

Annual Cash Flow Conversion Efficiency for VACCITECH (SP.ADR)/1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of VACCITECH (SP.ADR)/1 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see VACCITECH (SP.ADR)/1 stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€74.29 Million ≈ $86.86 Million	€-47.98 Million ≈ $-56.09 Million	-0.646x	-190.41%
2024-12-31	€130.13 Million ≈ $152.14 Million	€-28.94 Million ≈ $-33.83 Million	-0.222x	+18.34%
2023-12-31	€187.00 Million ≈ $218.62 Million	€-50.92 Million ≈ $-59.54 Million	-0.272x	-358.95%
2022-12-31	€243.20 Million ≈ $284.33 Million	€-14.43 Million ≈ $-16.87 Million	-0.059x	+54.01%
2021-12-31	€252.56 Million ≈ $295.27 Million	€-32.58 Million ≈ $-38.09 Million	-0.129x	--

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#25060 Global

#2170 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00